Meeting News

Right-sided colorectal tumors have worse outcomes

January 16, 2018
Patients with stage III and high-risk stage II colorectal cancer had worse DFS if they had right-sided tumors compared with left-sided tumors…
Meeting News

Liquid biopsy test detects early-stage colorectal cancer

January 16, 2018
A test that identifies circulating tumor cells present in the bloodstream accurately detected early-stage colorectal cancer, according to results of…

First-line Keytruda plus chemotherapy improves OS, PFS in non-small cell lung cancer

January 16, 2018
The addition of pembrolizumab to pemetrexed and cisplatin or carboplatin improved OS and PFS as first-line treatment for patients with metastatic…
FDA News

FDA approves Trisenox plus tretinoin as first-line therapy for acute promyelocytic leukemia

January 16, 2018
The FDA approved arsenic trioxide injection in combination with tretinoin for the treatment of patients with newly diagnosed low-risk acute…

Study underway to evaluate immunotherapy plus radiation for newly diagnosed sarcoma

January 16, 2018
A clinical trial is underway to assess use of two immunotherapy agents, durvalumab and tremelimumab, plus radiation therapy for the treatment of…
In the Journals Plus

Hematopoietic stem cell transplantation safe in patients with HIV

January 16, 2018
An analysis of hematopoietic stem cell transplant recipients in the United States over a 14-year period showed that patients with HIV do not have an…
In the Journals

Myeloproliferative neoplasms significantly increase thrombotic risk

January 15, 2018
The rate of arterial and venous thrombosis was significant in patients with myeloproliferative neoplasms, according to research published in…
In the Journals

Normal tissue BRCA1 linked to high-grade ovarian cancer risk

January 15, 2018
Patients with normal tissue BRCA1 methylation have a higher risk for ovarian cancer, especially high-grade serous ovarian cancer, according to…
In the Journals Plus

Delirium frequent among noncritically ill children with cancer

January 15, 2018
Delirium diagnoses occurred among 18.8% of hospitalized children with cancer appeared associated with longer hospital stays, according to a study…
FDA News

FDA expands approval of Gilotrif for advanced lung cancer with uncommon EGFR mutations

January 15, 2018
The FDA expanded the indication of afatinib to include the first-line treatment of patients with non-small cell lung cancer whose tumors have…
Meeting News

Brentuximab vedotin, nivolumab combination appears active for Hodgkin lymphoma

January 15, 2018
ATLANTA — A combination of brentuximab vedotin with nivolumab appeared tolerable and safe among patients with relapsed or refractory Hodgkin…

Opioid use associated with nonadherence to adjuvant endocrine therapy among breast cancer survivors

January 15, 2018
Opioid use appeared significantly associated with nonadherence to adjuvant endocrine therapy among a cohort of breast cancer survivors, according to…
In the Journals Plus

Chemotherapy use declines in early-stage breast cancer

January 14, 2018
The use and recommendation of chemotherapy for women with both node-negative and node-positive early-stage breast cancer has declined in recent…

Lymphoma specialist named associate director for clinical services at Rutgers Cancer Institute

January 14, 2018
Andrew M. Evens, DO, MSc, FACP, has been named associate director for clinical services at Rutgers Cancer Institute. In this role, he will oversee…

Physician-researcher joins Atlantic Health System

January 13, 2018
Mohamad Cherry, MD, has joined Atlantic Health System’s Atlantic Medical Group. Cherry most recently practiced at University of Oklahoma…
In the Journals Plus

Traditional systemic chemotherapy superior to targeted treatment for HER-2-positive breast cancer

January 12, 2018
Patients with HER-2-positive breast cancer appeared more likely to achieve pathologic complete response when treated with traditional neoadjuvant…
In the Journals Plus

Mismatch repair-deficient colorectal tumors no more common among Latinos

January 12, 2018
Latino patients with colorectal cancer had a 13% prevalence rate of mismatch repair-deficient tumors, a rate that appeared consistent with those of…
In the Journals Plus

Cardiovascular adverse events common with carfilzomib

January 12, 2018
Carfilzomib appeared linked with cardiovascular adverse events among patients receiving the drug for multiple myeloma, suggesting that phase 1…

$name

FDA News

FDA approves Lynparza, first treatment for BRCA-mutated breast cancer

January 12, 2018
The FDA expanded the indication of olaparib to include patients with germline BRCA-mutated, HER-2-negative metastatic breast cancer who were…